查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1579725

穿戴式註射器的全球市场

Wearable Injectors
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到2030年，全球穿戴式註射器市场预计将达到204亿美元

2023年全球穿戴式註射器市场预计为107亿美元，预计到2030年将达到204亿美元，2023-2030年分析期间复合年增长率为9.6%。体式註射器是本报告分析的细分市场之一，预计复合年增长率为 9.4%，到分析期结束时将达到 147 亿美元。在分析期间，离体注射器市场的复合年增长率预计为 10.1%。

美国市场预估成长29亿美元，中国预期复合年增长率9.0%

预计 2023 年美国穿戴式註射器市场规模将达 29 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达32亿美元，2023-2030年分析期间复合年增长率为9.0%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 8.5% 和 8.0%。在欧洲，德国的复合年增长率预计约为 7.5%。

全球穿戴式註射器市场－探索主要趋势和市场驱动因素

为什么穿戴式註射器将彻底改变药物传输领域？

穿戴式註射器已成为药物传输领域的突破性创新，为传统注射方法提供了一种方便且对患者友善的替代方案。但穿戴式註射器究竟会如何彻底改变现代医疗保健呢？穿戴式註射器是一种紧凑、用户友好的设备，设计用于皮下注射大量药物。这些设备佩戴在患者身上，可以连续或定期给药，无需重复手动注射。穿戴式註射器特别有利于注射生物製药，例如单株抗体、荷尔蒙和其他必须缓慢注射以避免副作用的高黏度製剂。它为患者提供了更舒适、侵入性更小的选择，使患者更容易坚持治疗方法，特别是对于需要频繁给药的慢性疾病。

推动穿戴式註射器需求的是需要长期药物管理的慢性疾病的流行，例如糖尿病、自体免疫疾病和心血管疾病。生物製药是许多此类疾病的标准治疗方法，但其复杂的给药方式对患者的依从性造成了障碍。穿戴式註射器让患者在家中自行给药，减少频繁去医院的需要并提高治疗依从性，从而解决了这项挑战。此外，穿戴式註射器在肿瘤学领域越来越受欢迎，它们用于以可控且舒适的方式註射化疗和支持治疗中使用的药物。随着製药业不断开发更多的生物製药，预计穿戴式註射器将在这些复杂药物的输送中发挥越来越重要的作用，以改善患者的治疗效果和生活品质。

科技进步如何提升穿戴式註射器的性能？

穿戴式註射器市场见证了显着的技术进步，提高了这些设备的安全性、效率和易用性。但推动这些发展的关键技术创新是什么？最显着的进步之一是将电子和数位技术整合到可穿戴注射器中，从而可以精确控制给药剂量和速率。现代穿戴式註射器配备了微处理器控制的机制，可提供准确且一致的药物输送，最大限度地减少剂量不足或过量的风险。此外，预先编程的给药方案为复杂的治疗方法提供了灵活性。透过智慧感测器和连接的集成，穿戴式註射器可以监测患者的用药依从性，并透过智慧型手机应用程式和连接的健康平台提供即时回馈。这种连接使患者和医疗保健提供者能够追踪给药历史、监控设备性能并在输注过程中出现问题时接收警报。

另一个关键创新是先进材料和人体工学设计的开发，提高了穿戴式註射器的舒适度和易用性。这些设备现在由轻质、生物相容性材料製成，符合身体轮廓，长时间佩戴舒适。由于黏合技术的创新，即使在运动期间，它现在也可以安全佩戴，不会刺激皮肤。可穿戴注射器设计也已发展到包括谨慎、易于使用的功能，例如易于操作的按钮、视觉和听觉指示器以及自动针头插入和缩回系统。这些进步降低了使用穿戴式註射器的复杂性，使更多患者可以使用它们，包括那些灵活性有限且视力不佳的患者。此外，自行注射训练工具和虚拟模拟的开发提高了患者使用这些设备的信心和熟练程度，有助于提高依从率和改善治疗结果。

哪些市场趋势正在推动穿戴式註射器在医疗保健领域的普及？

几个关键的市场趋势正在推动穿戴式註射器在各种医疗保健环境中的采用，反映了患者、医疗保健专业人员和製药公司不断变化的需求和偏好。最显着的趋势之一是以患者为中心的护理和治疗的自我管理的转变。随着对个人化医疗和家庭医疗保健的日益关注，可穿戴式註射器已成为想要在舒适的家用中管理治疗的患者的首选。这种趋势在需要连续给药或定期给药的慢性疾病的治疗中尤其明显。穿戴式註射器为患者提供了一种方便、谨慎且可靠的给药方式，无需频繁去医院或诊所就诊，从而为患者提供帮助。这不仅增加了患者的便利性，还减轻了医疗机构的负担，使穿戴式註射器成为寻求优化资源利用的医疗系统的有吸引力的选择。

推动穿戴式註射器采用的另一个重要趋势是生物製药和高黏度药物的使用增加。生物製药，包括各种治疗性蛋白质、抗体和激素，通常需要大量给药，而传统注射器或自动注射器无法轻鬆给药。可穿戴注射器透过允许在较长时间内控制输送高黏度製剂，提供了一种给药这些药物的解决方案。这扩大了可以自我管理的治疗范围，使更多患者能够家用接受生物製药治疗。此外，製药公司越来越多地与穿戴式註射器製造商合作，开发整合药物和设备的预填充单元组合产品。这些组合产品简化了药物传递过程，增加了患者的便利性，降低了剂量错误的风险，并促进了穿戴式註射器的进一步采用。随着生技药品市场的持续增长以及对患者友好的药物输送解决方案的需求增加，可穿戴注射器预计将成为许多治疗方法的标准组成部分。

推动全球穿戴式註射器市场成长的因素有哪些？

全球穿戴式註射器市场的成长受到多种因素的推动，例如药物输送技术的进步、慢性病盛行率的增加以及家庭医疗保健的日益普及。关键的成长要素之一是对用于治疗多种疾病的生物製药的需求不断增长，包括自体免疫疾病、癌症和荷尔蒙失调。生物製药非常适合透过穿戴式註射器输送药物，因为它们通常需要大剂量或长时间输注。生物製药产品线的不断扩大以及接受这些治疗的患者数量的不断增加，为可安全有效地输送这些复杂药物的可穿戴注射器创造了巨大的市场机会。製药公司越来越多地采用穿戴式註射器作为其药物发行策略的一部分，特别是对于需要患者坚持和长期管理的治疗。

另一个关键的成长要素是更重视提高病患用药依从性和治疗顺从性。不坚持注射治疗是慢性病管理的一个主要挑战，导致治疗效果不佳并增加医疗费用。穿戴式註射器透过提供更方便、侵入性更小的药物输送方法来解决这项挑战，减少与传统注射相关的频率和不适。穿戴式註射器还可以长时间输送药物，无需多次注射，使患者更容易遵守规定的治疗方案。穿戴式註射器整合了智慧技术和连接功能，进一步增强了其支援患者服药依从性的能力，包括提供提醒、监控给药历史以及促进与医疗保健提供者的沟通。

全球穿戴式註射器市场也受惠于扩大家庭医疗保健和远端医疗服务的成长趋势。随着医疗保健系统努力减少住院人数并提供离家更近的护理，穿戴式註射器正在成为远距病患管理的重要推动者。这些设备使患者无需亲自就诊即可接受复杂的治疗，满足了对居家输液服务和远端医疗解决方案不断增长的需求。此外，容易患慢性病和复杂药物治疗的老年人口的增加预计将推动穿戴式註射器市场的进一步成长。随着技术的不断发展和可穿戴注射器治疗方法范围的扩大，由于技术创新、患者需求和不断发展的医疗保健实践的动态相互作用，全球市场有望实现持续增长。

调查企业范例（共43例）

  • Amgen, Inc.
  • Becton, Dickinson and Company
  • Bespak Europe Ltd.
  • Enable Injections, Inc.
  • Insulet Corporation
  • Medtronic PLC
  • Sensile Medical AG
  • Tandem Diabetes Care, Inc.
  • United Therapeutics Corporation
  • Valeritas, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP16900

Global Wearable Injectors Market to Reach US$20.4 Billion by 2030

The global market for Wearable Injectors estimated at US$10.7 Billion in the year 2023, is expected to reach US$20.4 Billion by 2030, growing at a CAGR of 9.6% over the analysis period 2023-2030. On-Body injectors, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$14.7 Billion by the end of the analysis period. Growth in the Off-Body injectors segment is estimated at 10.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.9 Billion While China is Forecast to Grow at 9.0% CAGR

The Wearable Injectors market in the U.S. is estimated at US$2.9 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 9.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.5% and 8.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.

Global Wearable Injectors Market - Key Trends & Growth Drivers Explored

Why Are Wearable Injectors Revolutionizing the Drug Delivery Landscape?

Wearable injectors have emerged as a groundbreaking innovation in the drug delivery landscape, providing a convenient and patient-friendly alternative to traditional injection methods. But what exactly makes these devices so transformative in modern healthcare? Wearable injectors are compact, user-friendly devices designed to administer large volumes of medication subcutaneously over an extended period, typically ranging from several minutes to several hours. These devices are worn on the patient’s body, allowing for continuous or scheduled drug delivery without the need for repeated manual injections. Wearable injectors are particularly beneficial for administering biologic drugs, such as monoclonal antibodies, hormones, and other high-viscosity formulations that require slow infusion to avoid adverse reactions. They offer a more comfortable and less invasive option for patients, making it easier to adhere to treatment regimens, especially for chronic conditions that require frequent dosing.

The demand for wearable injectors is being driven by the growing prevalence of chronic diseases such as diabetes, autoimmune disorders, and cardiovascular conditions, which require long-term medication management. For many of these conditions, biologics have become the standard of care, but their complex administration can be a barrier to patient adherence. Wearable injectors address this challenge by enabling patients to self-administer medications in a home setting, reducing the need for frequent clinic visits and improving treatment compliance. Additionally, wearable injectors are gaining traction in oncology, where they are used to deliver chemotherapy and supportive care medications in a controlled and comfortable manner. As the pharmaceutical industry continues to develop more biologic therapies, wearable injectors are expected to play an increasingly critical role in delivering these complex drugs, improving patient outcomes and overall quality of life.

How Are Technological Advancements Elevating the Performance of Wearable Injectors?

The wearable injectors market has witnessed significant technological advancements that have enhanced the safety, efficiency, and usability of these devices. But what are the key innovations driving these developments? One of the most notable advancements is the integration of electronic and digital technologies into wearable injectors, enabling precise control over dosing and delivery rates. Modern wearable injectors are equipped with microprocessor-controlled mechanisms that ensure accurate and consistent drug delivery, minimizing the risk of under- or overdosing. These devices can also include pre-programmed dosing schedules, providing flexibility for administering complex treatment regimens. The integration of smart sensors and connectivity features allows wearable injectors to monitor patient adherence and provide real-time feedback through smartphone apps or connected health platforms. This connectivity enables patients and healthcare providers to track dosing history, monitor device performance, and receive alerts if any issues arise during the infusion process.

Another critical innovation is the development of advanced materials and ergonomic designs that enhance the comfort and usability of wearable injectors. These devices are now made from lightweight, biocompatible materials that conform to the body’s contours, making them comfortable to wear for extended periods. Innovations in adhesive technology have improved the device’s ability to remain securely attached to the skin without causing irritation, even during physical activity. The design of wearable injectors has also evolved to include discreet and user-friendly features such as easy-to-activate buttons, visual and audible indicators, and automatic needle insertion and retraction systems. These advancements have reduced the complexity of using wearable injectors, making them more accessible to a broader range of patients, including those with limited dexterity or vision. Furthermore, the development of self-injection training tools and virtual simulations has helped improve patient confidence and proficiency in using these devices, contributing to higher adherence rates and better therapeutic outcomes.

What Market Trends Are Driving the Adoption of Wearable Injectors Across Healthcare Settings?

Several key market trends are shaping the adoption of wearable injectors across various healthcare settings, reflecting the evolving needs and preferences of patients, healthcare providers, and pharmaceutical companies. One of the most prominent trends is the shift towards patient-centric care and self-administration of therapies. With the increasing focus on personalized medicine and home-based healthcare, wearable injectors have become a preferred option for patients who want to manage their treatments in the comfort of their own homes. This trend is particularly strong in the management of chronic diseases, where continuous drug delivery and regular dosing are required. Wearable injectors empower patients by providing them with a convenient, discreet, and reliable means of administering their medications without the need for frequent hospital or clinic visits. This not only enhances the patient experience but also reduces the burden on healthcare facilities, making wearable injectors an attractive option for healthcare systems looking to optimize resource utilization.

Another key trend driving the adoption of wearable injectors is the increasing use of biologic therapies and high-viscosity drugs. Biologics, which include a range of therapeutic proteins, antibodies, and hormones, are often administered in large volumes that cannot be easily delivered using traditional syringes or autoinjectors. Wearable injectors provide a solution for administering these drugs by allowing for the controlled delivery of high-viscosity formulations over an extended period. This has expanded the range of treatments that can be self-administered, making it possible for more patients to receive biologic therapies at home. Additionally, pharmaceutical companies are increasingly collaborating with wearable injector manufacturers to develop combination products that integrate the drug and device into a single, pre-filled unit. These combination products simplify the drug delivery process, enhance patient convenience, and reduce the risk of dosing errors, driving further adoption of wearable injectors. As the market for biologics continues to grow and the need for patient-friendly drug delivery solutions increases, wearable injectors are expected to become a standard component of many therapeutic regimens.

What Factors Are Driving the Growth of the Global Wearable Injectors Market?

The growth in the global wearable injectors market is driven by several factors, including advancements in drug delivery technology, the increasing prevalence of chronic diseases, and the rising adoption of home healthcare. One of the primary growth drivers is the rising demand for biologic therapies, which are used to treat a wide range of conditions, including autoimmune diseases, cancer, and hormonal disorders. Biologic drugs are often administered in high volumes or require prolonged infusion times, making them ideal candidates for delivery via wearable injectors. The expanding pipeline of biologic drugs, coupled with the increasing number of patients receiving these therapies, has created a significant market opportunity for wearable injectors that can deliver these complex drugs safely and effectively. Pharmaceutical companies are increasingly adopting wearable injectors as part of their drug delivery strategies, particularly for therapies that require patient adherence and long-term management.

Another key growth driver is the increasing focus on improving patient adherence and compliance with therapy. Poor adherence to injectable therapies is a major challenge in chronic disease management, leading to suboptimal treatment outcomes and increased healthcare costs. Wearable injectors address this challenge by providing a more convenient and less invasive method of drug delivery, reducing the frequency and discomfort associated with traditional injections. The ability of wearable injectors to deliver drugs over an extended period also reduces the need for multiple injections, making it easier for patients to adhere to their prescribed regimens. The integration of smart technology and connectivity features in wearable injectors has further enhanced their ability to support patient adherence by providing reminders, monitoring dosing history, and facilitating communication with healthcare providers.

The global wearable injectors market is also benefiting from the increasing trend towards home-based healthcare and the expansion of telemedicine services. As healthcare systems strive to reduce hospital admissions and provide care closer to home, wearable injectors are becoming a key enabler of remote patient management. These devices allow patients to receive complex therapies without the need for in-person visits, supporting the growing demand for home infusion services and telehealth solutions. Moreover, the rising geriatric population, which is more susceptible to chronic diseases and complex medication regimens, is expected to drive further growth in the wearable injectors market. As the technology continues to evolve and the range of therapies administered via wearable injectors expands, the global market is poised for sustained growth, driven by a dynamic interplay of innovation, patient demand, and evolving healthcare practices.

Select Competitors (Total 43 Featured) -

  • Amgen, Inc.
  • Becton, Dickinson and Company
  • Bespak Europe Ltd.
  • Enable Injections, Inc.
  • Insulet Corporation
  • Medtronic PLC
  • Sensile Medical AG
  • Tandem Diabetes Care, Inc.
  • United Therapeutics Corporation
  • Valeritas, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Wearable Injectors - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Self-Administration and Home-Based Drug Delivery Solutions Drives Growth of Wearable Injectors Market
    • Increased Adoption of Wearable Injectors in Chronic Disease Management Expands Addressable Market
    • Surge in Demand for Wearable Injectors in Diabetes and Insulin Delivery Fuels Market Growth
    • Rising Adoption of Wearable Injectors in Oncology and Biologic Drug Delivery Sets the Stage for Market Growth
    • Surge in Use of Wearable Injectors in Hormone and Pain Management Therapies Expands Market Opportunities
    • Technological Innovations in Micro-Needle and Patch-Based Wearable Injectors Propel Market Growth
    • Increased Utilization of Wearable Injectors in Rheumatology and Immunology Drug Delivery Fuels Market Demand
    • Rising Focus on Reducing Hospital Visits and Healthcare Costs Drives Adoption of Wearable Injectors
    • Surge in Demand for Wearable Injectors in Cardiology and Endocrinology Applications Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Wearable Injectors Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Wearable Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Wearable Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for On-Body injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for On-Body injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Off-Body injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for Off-Body injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Immuno-oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Immuno-oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Other Therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Spring Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for Spring Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Motor Driven by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World 7-Year Perspective for Motor Driven by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Rotary Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 19: World 7-Year Perspective for Rotary Pump by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Battery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World 7-Year Perspective for Battery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World 7-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Semi-Reusable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 25: World 7-Year Perspective for Semi-Reusable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Disposable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World 7-Year Perspective for Disposable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Wearable Injectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 28: USA Recent Past, Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 29: USA 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2024 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 31: USA 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2024 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 35: USA 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2024 & 2030
  • CANADA
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 37: Canada 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2024 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 41: Canada 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2024 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 43: Canada 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2024 & 2030
  • JAPAN
    • Wearable Injectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2024 & 2030
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Japan 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2024 & 2030
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Japan 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2024 & 2030
  • CHINA
    • Wearable Injectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 52: China Recent Past, Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 53: China 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2024 & 2030
    • TABLE 54: China Recent Past, Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 55: China 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2024 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 59: China 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2024 & 2030
  • EUROPE
    • Wearable Injectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Wearable Injectors by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 61: Europe 7-Year Perspective for Wearable Injectors by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2024 & 2030
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Europe 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2024 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Europe 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2024 & 2030
  • FRANCE
    • Wearable Injectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 70: France Recent Past, Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 71: France 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2024 & 2030
    • TABLE 72: France Recent Past, Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 73: France 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2024 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: France 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2024 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 77: France 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2024 & 2030
  • GERMANY
    • Wearable Injectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 78: Germany Recent Past, Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 79: Germany 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2024 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Germany 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2024 & 2030
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 83: Germany 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2024 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 85: Germany 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2024 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Italy 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2024 & 2030
    • TABLE 88: Italy Recent Past, Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 89: Italy 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2024 & 2030
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 91: Italy 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2024 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Italy 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2024 & 2030
  • UNITED KINGDOM
    • Wearable Injectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 94: UK Recent Past, Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 95: UK 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2024 & 2030
    • TABLE 96: UK Recent Past, Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 97: UK 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2024 & 2030
    • TABLE 98: UK Recent Past, Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: UK 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2024 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 101: UK 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 102: Rest of Europe Recent Past, Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 103: Rest of Europe 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2024 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Europe 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2024 & 2030
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2024 & 2030
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Wearable Injectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2024 & 2030
    • TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 113: Asia-Pacific 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2024 & 2030
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2024 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 118: Rest of World Recent Past, Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 119: Rest of World 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2024 & 2030
    • TABLE 120: Rest of World Recent Past, Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 121: Rest of World 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2024 & 2030
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of World 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2024 & 2030
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 125: Rest of World 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2024 & 2030

IV. COMPETITION